SHUFRO ROSE & CO LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHUFRO ROSE & CO LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2021$288,000
-5.3%
1,300
-43.5%
0.02%
-8.3%
Q1 2021$304,000
-46.8%
2,300
-30.3%
0.02%
-50.0%
Q4 2020$571,000
+55.6%
3,3000.0%0.05%
+33.3%
Q3 2020$367,000
+81.7%
3,300
+10.0%
0.04%
+50.0%
Q1 2020$202,000
-60.6%
3,000
-50.8%
0.02%
-47.8%
Q4 2019$513,000
-4.8%
6,100
-15.3%
0.05%
-14.8%
Q3 2019$539,0007,2000.05%
Other shareholders
NOVOCURE LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders